2019 CYIR Finalized

21 Summary This article reports on the relatively new finding that T-helper (Th) 17.1 cells play a dominant role in the exag- gerated interferon-γ production in sarcoidosis lungs. In this study, the authors investigated 1) whether Th17.1 cells are increased in the lung-draining mediastinal lymph nodes (MLNs) of sarcoidosis patients and 2) whether frequen- cies of the Th17.1 cells at diagnosis correlate with disease progression. MLN cells from treatment-naive pulmonary sarcoidosis patients (n=17) and healthy controls (n=22), and peripheral blood mononuclear cells (n=34) and bron- choalveolar lavage fluid (BALF) (n=36) from sarcoidosis patients were examined for CD4+ T-cell subset proportions using flow cytometry. Higher proportions of Th17.1 cells were detected in sarcoidosis MLNs than in control MLNs. Higher Th17.1 cell proportions were found in sarcoidosis BALF compared to MLNs and peripheral blood. Of poten- tial clinical importance, BALF Th17.1 cell proportions were significantly higher in patients developing chronic disease than in patients undergoing resolution within 2 years of clinical follow-up. Comments 1. Data demonstrate that T-cells bearing a surface Th17.1 pheno- type are excessively present in the sarcoidosis lung (bronchoal- veolar lavage) and adjacent mediastinal lymph nodes. 2. The results suggest that Th17.1/Th1 ratio could serve as a novel prognostic indicator of disease course. 3. On the contrary, a recent study from Sweden has shown that Th17.1 cells are associated with disease remission (Kaiser et al. Eur Respir J 2016;48:484-94). 4. The observations provide reasons for investigating treatments targeting the Th17 pathway. 5. Whether expression of IL17 trumps interferon-γ as a biomarker for disease activity in sarcoidosis will need further study. GENETICS OF SARCOIDOSIS Besnard V, Calender A, Bouvry D, Pacheco Y, Chapelon- Abric C, Jeny F, Nunes H, Planès C, Valeyre D. G908R NOD2 variant in a family with sarcoidosis. Respir Res 2018; 19(1): 44. Summary The article describes interesting genetic findings in a fam- ily with sarcoidosis. Sarcoidosis is a systemic disease characterized by the formation of immune granulomas in various organs, mainly the lungs and the lymphatic system. Exaggerated granulomatous reaction might be triggered in response to unidentified antigens in individuals with genetic susceptibility. The authors aimed to determine the genetic variants implicated in a familial case of sarcoidosis. They evaluated the clinical presentation and history, NOD2 pro- file, NF-κB and cytokine production in blood monocytes/ macrophages in individuals from a family with late appear- ance of sarcoidosis. In their case of familial sarcoidosis with typical thoracic sarcoidosis they found carriage of the NOD2 2722G>C variant. This variant was associated with the presence of three additional SNPs for the IL17RA, KALRN and EPHA2 genes, which discriminated patients expressing the disease from others. Despite a decrease in NF-κB activity, IL-8 and TNF-A mRNA levels were increased at baseline and in stimulated conditions. Comments 1. So far no convincing involvement of NOD2 mutations in sar- coidosis pathogenesis was evidenced. 2. This interesting case report however shows that the combi- nation of polymorphisms in the NOD2, IL17RA, EPHA2 and KALRN genes might play a role. 3. The combination of polymorphisms in these genes could pos- sibly contribute to a chronic pro-inflammatory status of macro- phages. 4. Future functional studies are required to reveal the causal regu- latory variation of the various loci and the immunogenetic basis related to sarcoidosis. SARCOIDOSIS

RkJQdWJsaXNoZXIy MTM1ODMw